Ifp Advisors, Inc Terns Pharmaceuticals, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TERN
# of Institutions
135Shares Held
84.9MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$151 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$140 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$138 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$134 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$127 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $694M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...